Table 1 The progression and mortality of mild or moderate patients in control group
Literature | Country | Time of case occurrence | Number of mild or moderate | Number of progression | Progression rate (%) | Number of deaths | Mortality (%) |
|---|---|---|---|---|---|---|---|
Wang et al. [13] | Tianjin, China | January to March 2020 | 95 | 22 | 23.2 | 0 | 0 |
Higuchi et al. [14] | Japan | February to June 2020 | 37 | 0 | 0 | 0 | 0 |
Iijima et al. [15] | Japan | April to May 2020 | 55 | 6 | 10.9 | NR | NR |
Cheng et al. [16] | Hubei, China | January to March 2020 | 456 | 205 | 45.0 | 46 | 10.1 |
Wang et al. [17] | Hubei, China | February to April 2020 | 1758 | 474 | 27.0 | 9 | 0.5 |
Long et al. [18] | Hubei, China | January to February 2020 | 253 | 48 | 19.0 | 5 | 2.0 |
Jiang et al. [19] | Hubei, China | January to April 2020 | 213 | 35 | 16.4 | NR | NR |
Zhang et al. [20] | Guangdong, China | January to February 2020 | 12 | 1 | 8.3 | 0 | 0 |
Li et al. [21] | Anhui, China | January to February 2020 | 65 | 24 | 36.9 | 0 | 0 |
Liang et al. [22] | Guangdong, China | January to February 2020 | 204 | 28 | 13.7 | 0 | 0 |
Zhang et al. [23] | Sichuan, China | 2020 | 98 | 31 | 31.6 | 0 | 0 |
Lang et al. [24] | Sichuan, China | January to February 2020 | 17 | 5 | 29.4 | 0 | 0 |
Liu et al. [25] | Hubei, China | January to February 2020 | 62 | 10 | 16.1 | 6 | 9.7 |
Duan et al. [26] | Chongqing, China | January to February 2020 | 348 | 20 | 5.7 | NR | NR |
Lv et al. [27] | Beijing, China | January to February 2020 | 64 | 13 | 20.3 | 0 | 0 |
Luo et al. [28] | Jiangsu, China | January to February 2020 | 597 | 36 | 6.0 | 0 | 0 |
Zhao et al. [29] | Hubei, China | February 2020 | 172 | 60 | 34.9 | NR | NR |
Wang et al. [30] | Shenzhen, China | January to February 2020 | 323 | 70 | 21.7 | 3 | 0.9 |
Lu et al. [31] | Shanghai, China | January to February 2020 | 44 | 18 | 40.9 | 0 | 0 |